-
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial.
Paolo Giovanni Nuciforo, John Townend, Cristina Saura, E. de Azumbaja, Florentine Hilbers, Anna Manukyants, +13 more
3citations -
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response
Mark Schuiveling, Isabella A.J. van Duin, Laurens S. ter Maat, Rik Jasper Verheijden, Franchette W.P.J. van den Berkmortel, Gerben Eise Breimer, +14 more
2citations -
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry2023 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Jesper van Breeschoten, Alfons J.M. van den Eertwegh, Doranne L. Hilarius, John B.A.G. Haanen, Christian U. Blank, Maureen J.B. Aarts, +14 more
2citations -
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo Giulio Baldi, Claudia Giani, Silva Ljevar, Ryan A. Denu, Andrea Napolitano, Ilkyu Han, +35 more
2citations -
SNP rs10748643 within the promoter region of ENTPD1 (the gene encoding CD39) has no prognostic value in Sézary patients2023 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access
Yixin Luo, Kees Tensen, Willem H. Zoutman, Safa Najidh, Koen D. Quint, Maarten H. Vermeer
2citations -
International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100
Louis Fox, Marieke van Leeuwen, Jennifer M. Jones, Amal Al‐Omari, Haneen Abaza, Muna Alkhaifi, +57 more
2citations -
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancer2026 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access
Nicole D Hildebrand, David P.J. van Dijk, Jisce R. Puik, Anne Claire Henry, Paul C. M. Andel, Esther N. Dekker, +28 more
1citations -
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review
Marit Ahrens, John B.A.G. Haanen, Laurence K. Albiges, Marine Gross‐Goupil, Ekaterini Boleti, Gwénaëlle Gravis, +29 more
1citations -
Corrigendum to ‘Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients’ [Eur J Cancer 141 (2020) 128-136]
Ibtissam Acem, Cornelis Kees Verhoef, Anja J. Rueten‐Budde, Dirk Jan Grünhagen, Winan J. van Houdt, Michiel A. J. van de Sande, +30 more
1citations -
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways
Lotte L. Hoeijmakers, Elisa A. Rozeman, Marta López‐Yurda, Lindsay G. Grijpink-Ongering, Birthe C. Heeres, Bart A. van de Wiel, +10 more
1citations -
Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes2026 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access
Merlijn U.J.E. Graus, Aniek E. van Diepen, Thijmen H.T. Broekman, Casper W.F. van Eijck, Jeanin Elise van Hooft, Marjolein Y.V. Homs, +6 more
1citations -
Standardising definitions, endpoints, and reporting parameters for clinical studies of stereotactic body radiation therapy in bone metastases: An international Delphi consensus
Shing Fung Lee, Henry C. Y. Wong, Eva Oldenburger, Srinivas Raman, Gustavo Nader Marta, Adrian W. Chan, +18 more
1citations -
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis2025 European Journal of Cancer article Mathematics Statistical Methods in Clinical Trials Open access
Alexander Dean Sherry, Pavlos Msaouel, Avital M. Miller, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, +6 more
1citations -
Association of germline genetic variants with breast cancer survival in patient subgroups defined by standard clinic-pathological variables2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer
Anna Morra, Maria Escala-Garcia, Sander Canisius, Renske Keeman, Montserrat García‐Closas, Paul D.P. Pharoah, +1 more
1citations